Problem
Secrecy about pharmaceutical products
Other Names:
Lack of public access to information on medicines Incidence:
In the UK, it is a criminal offence for officials involved in the licensing or withdrawal of a drug to disclose any information about their decision. Although the manufacturers of drugs are required to produce data sheets that identify likely side-effects, there is no public right of access to these safety studies.
Broader Problems:
Inaccessibility of knowledgeUnethical pharmaceutical practicesSecrecy of medical facts and records Related Problems:
Environmental secrecyInadequate drug classificationUnavailability of quality medicine Strategies:
Maintaining secrecy about pharmaceutical productsProviding public information on medicinesAbstaining from public access to information on medicinesExposing misleading pharmaceutical publicity Subject(s):
Defence → SecrecyGovernment → Public
Health Care → Pharmacy
Industry → Products
Information → Information
Societal Problems → Scarcity
Related UN Sustainable Development Goals:
Problem Type:
F: Fuzzy exceptional problems Date of last update
31.03.2022 – 08:51 CEST